Puyallup, WA – Western IRB (WIRB), the world's largest provider of ethical research review serving 2,300 academic medical centers (AMCs) and hospitals, announced today an alliance with Huron, a global professional services firm serving the health care, higher education, life sciences, and commercial sectors.
WIRB’s and Huron’s combined strengths can help institutions improve the effectiveness of clinical research for the development of new pharmaceuticals and medical devices. The alliance will provide clients with a wide range of administrative and clinical services that are integrated with empowering technologies to ease the financial, regulatory, and operational responsibilities of performing essential clinical research.
“Today, a number of factors have combined to make the conduct of clinical research challenging for many AMCs, hospitals, and their researchers. These programs are facing a reduction in government-sponsored research grants, coupled with an increase in regulatory requirements,” said Donald Deieso, PhD, chairman and chief executive officer of WIRB-Copernicus Group. “They must respond by attracting external research funding, conducting research with improved financial management, and streamlining administrative burdens. By combining the extensive experience of WIRB and Huron in serving this community, we intend to provide comprehensive solutions that will have a positive impact for our clients at this important moment of change.”
Huron assists AMCs, cancer centers, health systems, and community hospitals in managing their research programs. Huron has helped 99 of the nation’s top 100 research universities and more than half of the largest U.S. health systems achieve meaningful improvements.
Currently, more than 70 percent of AMCs and hospitals in the U.S. have named WIRB as their IRB-of-record for industry-funded research and regulatory advice and oversight.
“WIRB is quite simply the most trusted independent IRB partner to academic medical centers and hospitals,” said Stuart Horowitz, PhD, MBA, president of institutions for WIRB-Copernicus Group. “WIRB’s gold standard reputation with institutions, coupled with its deeply connected client base of industry research partners, provides a tremendous platform upon which institutions can grow their research programs.
“When you combine WIRB’s capabilities with those of Huron, institutions now have a complete solution to address all their research administration challenges,” Horowitz added.
For more information about WIRB, visit www.wirb.com.
About Western IRB
Founded in 1968, was the first independent review board and the pioneer of ethical review. It is now the trusted partner for more than 2,300 institutions in the U.S. alone. Western IRB is a member of the WIRB-Copernicus IRB Group, one of the divisions of WCG, Inc. - the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protections.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.